Yoshioka T, Fukuda H, Fujiwara T, Iwata R, Ido T, Murakawa Y, Gamo M, Ishioka C, Kanamaru R
Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Clin Nucl Med. 1999 Apr;24(4):261-3. doi: 10.1097/00003072-199904000-00009.
Fluorine-18-2-deoxy-2-fluoro-D-glucose (F-18 FDG) PET may be more suitable for follow-up after cancer treatment than other morphologic approaches, because it reflects tumor viability. A patient with abdominal lymph node metastases from colon cancer was followed by CT and F-18 FDG PET during chemotherapy. F-18 FDG PET tumor images changed in accordance with the clinical progress, whereas CT findings were relatively unchanged. This case clearly shows the utility of F-18 FDG PET for follow-up during cancer chemotherapy.
氟-18-2-脱氧-2-氟-D-葡萄糖（F-18 FDG）正电子发射断层显像（PET）在癌症治疗后的随访中可能比其他形态学检查方法更合适，因为它能反映肿瘤的活性。一名患有结肠癌腹部淋巴结转移的患者在化疗期间接受了CT和F-18 FDG PET检查。F-18 FDG PET肿瘤图像随临床进展而变化，而CT检查结果相对无变化。该病例清楚地显示了F-18 FDG PET在癌症化疗随访中的作用。
